The Times of India. Revised MRPs for 1,364 anti-cancer formulations across 121 drugs came into effect on November 9, after the government capped trade margins on 137 anti-cancer drugs.. The NPPA has capped trade margins on 137 non-scheduled anti-cancer drugs at 30%. The reductions promise major savings, though costly patented therapies may see limited relief.